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Introduction: Percutaneous implants, such as bone conduction hearing implants,
suffer from complications that include inflammation of the surrounding skin. A sealed
skin–abutment interface can prevent the ingress of bacteria, which should reduce the
occurrence of peri-abutment dermatitis. It was hypothesized that a hydroxyapatite (HA)-
coated abutment in conjunction with soft tissue preservation surgery should enable
integration with the adjacent skin. Previous research has confirmed that integration is
never achieved with as-machined titanium abutments. Here, we investigate, in vivo, if
skin integration is achievable in patients using a HA-coated abutment.
Materials and methods: One titanium abutment (control) and one HA-coated abutment
(case) together with the surrounding skin were surgically retrieved from two patients
who had a medical indication for this procedure. Histological sections of the skin were
investigated using light microscopy. The abutment was qualitatively analyzed using
scanning electron microscopy.
Results: The titanium abutment only had a partial and thin layer of attached amorphous
biological material. The HA-coated abutment was almost fully covered by a pronounced
thick layer of organized skin, composed of different interconnected structural layers.
Conclusion: Proof-of-principle evidence that the HA-coated abutment can achieve
integration with the surrounding skin was presented for the first time.
Keywords: skin integration, bone conduction hearing implant, hydroxyapatite, adverse skin reactions, SEM,
histology, Baha
Introduction
For many decades, research has focused on enhancing clinical outcomes with percutaneous (skin-
penetrating) implants, which have a broad application in medicine (1–3). Persistent or recurring
inflammation and/or infection of the soft tissues around the implant lead to significant morbidity.
These complications are also an important factor in the associated costs of these devices (4).
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The mechanisms of the inflammatory reaction around a
skin-penetrating device are not completely understood, but are
supposed to include infections by bacterial and fungal pathogens
(5, 6), a foreign body reaction (FBR) (7, 8), and shear stresses from
surrounding soft tissues (9, 10). The current leading hypothesis
and consensus is that “sealing” the skin–implant interface should
lead to better clinical outcomes. This could possibly be achieved
by impeding the epidermis from migrating downwards alongside
the implant (11). A healthy dermal collagenous matrix and
epithelial cells attached to the implant could provide a natural
border inhibiting this migration (2, 12). The tight connection
between the viable host tissues and the implant is believed to be
the key in preventing the formation of a moist pocket around the
implant and preventing pathogens from colonizing the implant
surface.
It is believed that skin integration is a race between the
host’s skin and bacterial growth on the implant surface (13, 14).
Whichever comes first or is the most pronounced could deter-
mine the clinical outcome. In vitro, as a proxy for the ability of
human skin tissues to integrate to implants, the ability of ker-
atinocytes to adhere and proliferate on different implant materials
have been investigated (15). The translation of these findings,
which are often contradictive (16), to clinical applications have
not been forthcoming. A promising biomaterial, hydroxyapatite
(HA), has been proposed to serve as a biocompatible coating over
the implant and to integrate with the skin (17). After evidence
of achieving skin integration in animals (12), Kang et al. claim
to have developed HA-coated flanged implants that were able to
integrate to the human skin in both limb (18) and extra-oral
craniofacial prostheses (19). Although featuring a small num-
ber of subjects and relying on subjective surgical outcome mea-
sures, these studies showed the potential of HA for cutaneous
integration.
The bone conduction hearing implant system, previously
referred to as a Bone-Anchored Hearing Aid (20), is under inves-
tigation here. It is a system that is worn behind the ear com-
prising an osseointegrated implant with a percutaneous abutment
attached. An external sound processor converts sound to vibra-
tions that elicit the perception of sound in the cochlea via bone
conduction. The sound processor can be coupled to the abutment
by patients as they please. Today, more than 100,000 patients
worldwide use this system in order to improve their hearing. The
system suffers from the same problems as other percutaneous
implants with peri-abutment dermatitis occurring in up to 38% of
patients (21). Nowadays, as an alternative to a percutaneous abut-
ment, several new transcutaneous systems exist where the skin
is not permanently breached (22). These solutions are promising
in their complication rates and cosmetic aspects but because of
different amplification needs for distinct patient groups they do
not remove the necessity of a percutaneous system.
Over the years, research was primarily focused on enhancing
the surgical technique for placement of the percutaneous bone
conduction hearing implant (23). These techniques all included
soft tissue reduction to reduce skinmotion and limit the formation
of deep epidermal pockets, which was believed to be essential
to maintaining acceptable complication rates. As it turns out,
solely adapting the surgical procedure did not bring the incidence
of inflammation, as classified by the Holgers grade (24), down
to the rate of its physiological counterparts, such as teeth (25).
Previously, it has been concluded that soft tissue integration is not
established with all-titanium bone conduction hearing implants
(6). The surface of removed as-machined titanium abutments was
mostly characterized by the absence of attaching cells. An amor-
phous layer, supposedly composed of proteins, bacteria, fungi,
leukocytes and shed, keratinized epithelial cells, was sometimes
observed (6). This amorphous material has also been associated
with biofilm (26).
Although a strict definition of soft tissue integration is lacking,
the current consensus includes physical locking by a viable and
vascularized layer of tissue tightly connecting the implant surface
to the host to prevent microbial colonization (13, 27, 28).
Recently, one of the manufacturers of bone conduction hearing
implant systems introduced an HA-coated titanium abutment
(Figure 1). It is designed for soft tissue integration and histological
evidence of an intimate tissue-to-abutment contact was previously
shown in an animal study (29). In contrast to all of its titanium
predecessors, the HA-coated abutment was able to form dermal
attachments and reduce epidermal downgrowth. Both can be seen
as signs of skin integration (29).
To our knowledge, this is the first soft tissue integration project
that is designed to translate and substantiate findings from basic
research to its clinical application. Within this project, proof-
of-principle and exploratory clinical investigations evaluating
the skin integration at structural and ultrastructural levels are
FIGURE 1 | Comparison of abutments (1). The all-titanium Cochlear Baha BA300 Abutment (A) and HA-coated BA400 abutment (B) are shown alongside SEM
images of their respective surfaces. The partial HA coating is white in the illustration (B). Both abutments connect to the same implant fixture (2).
Frontiers in Surgery | www.frontiersin.org September 2015 | Volume 2 | Article 452
van Hoof et al. Skin integration with a percutaneous hydroxyapatite-coated abutment
complemented by a large-scale randomized controlled trial focus-
ing on clinical and health-economic parameters in which over 100
patients have already been operated on (30). The present proof-of-
principle study aims to determine if the percutaneous HA-coated
abutment can achieve skin integration in patients.
Materials and Methods
Ethics
The procedures in this investigationwere in accordancewith legis-
lation (the Medical Research Involving Human Subjects Act) and
ethical standards on human experimentation in the Netherlands.
No approval was sought from an ethics committee beforehand as
it is not required when using materials derived from anonymized
patients that can be considered waste products from surgery. Only
patients who primarily had a medical indication for the surgical
removal of the abutment, including the surrounding skin, were
invited to participate. Verbal informed consent was gained prior
to the removal for the specific aim of informing the patients that
their data and materials would be collected during surgery. The
informed consent was noted in the electronic patient dossier.
The materials and patient records were subsequently coded and
anonymized. The individuals whose samples are presented in this
manuscript have provided written informed consent to publish
these case details.
Implants
Two types of abutments were evaluated in this study. The 6-mm-
long titanium abutment (Cochlear™ Baha® BA300 Abutment,
Cochlear Bone Anchored Solutions AB, Mölnlycke, Sweden) is
manufactured from medical grade titanium (Figure 1A) and fea-
tures an as-machined surface finish. The 10-mm-long HA-coated
titanium abutment (Cochlear Baha BA400 Abutment, Cochlear
Bone Anchored Solutions AB, Mölnlycke, Sweden) is also man-
ufactured frommedical grade titanium (Figure 1B) but features a
plasma-sprayed HA coating. The HA coating covers 7mm of the
total abutment length starting from the base. The upper titanium
part of this abutment, which is intended to protrude above skin
level, is not coated. Both abutments are supplied mounted on a
Cochlear Baha BI300 Implant fixture.
Scanning Electron Microscopy
The retrieved abutments were directly fixed after removal in a 3%
glutaraldehyde 0.1 M phosphate buffer (PB). These were rinsed
in PB and subsequently dehydrated in ascending concentrations
of alcohol (70 and 90% for 15min and twice in 100% alcohol
for 30min). The samples were critical-point dried and fixed to a
mount with carbon paint and metalized with gold. The presence
of attached tissues and cells was visually inspected using a Philips
XL30® scanning electron microscope (Philips, Eindhoven, the
Netherlands) on both abutments using high magnifications.
Light Microscopy
For histology, tissue specimens were fixed in 4% paraformalde-
hyde 0.1M PB at room temperature. The samples were washed
with 0.09 M monopotassium phosphate +7.5% sucrose to avoid
chemical reactions between glutaraldehyde and osmium. After-
wards, they were post fixed with 1% osmium tetraoxide in
a veronal buffer +1.5% ferrocyanide pH 7.4 at 4°C for 1 h.
They were rinsed in a veronal buffer +7% sucrose at 4°C for
5min. The specimens were subsequently dehydrated in ascend-
ing concentrations of alcohol (70% and 90% for 15min and
twice in 100% alcohol for 30min). The specimens were placed
twice in propylene oxide (PO) for 30min. After this step, they
were kept in a new resin embedding (Epon mix with PO 1:1)
overnight. On the next day, the samples were embedded in an
embedding capsule and polymerized with fresh Epon for 72 h
at 50°C. After fixation, the samples were cut into 1-μm slides
and stained with toluidine blue. Examinations were performed
using anOlympus BX51microscope (Olympus Europe,Hamburg,
Germany).
Results
Patient Reports
Patient 1 (Table 1) was a 25-year-old female implanted with the
titanium abutment 2 years previously. The abutment was placed
using the recommended surgical procedure at the time, which
was a linear incision with soft tissue thinning (31). Her history of
disease included constitutional eczema and otitis externa. She had
recurring and persistent episodes of peri-abutment dermatitis,
TABLE 1 | Demographics and clinical outcomes of two Baha users.
Patient 1 Patient 2
Age (years) 25 68
Sex Female Male
Relevant underlying conditions and
medication usage
Constitutional eczema, otitis externa. –
Type of implant Titanium abutment (BA300 Abutment) HA-coated abutment (BA400 Abutment)
Abutment in place (years) 2 1
Surgical placement technique Retro-auricular linear incision with soft tissue thinning. Retro-auricular linear incision without soft tissue thinning.
Reason for removal Severe, recurring, and persistent peri-abutment
dermatitis (Holgers grade 4).
Received a Cochlear Implant on the side of the Baha.
Complications related to the implant Severe, recurring, and persistent peri-abutment
dermatitis (Holgers grade 4). On removal, only redness
and moistness were present (Holgers grade 2).
Several episodes of redness, moistness, and granulation formation
around the Baha (Holgers grades 1–3). At the time of removal, the
skin adjacent to the Baha was only mildly red (Holgers grade 1).
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which were clinically unrelated to the constitutional eczema. The
inflammation was unresponsive to topical and systemic antibi-
otics (classified as a Holgers grade 4). This eventually led to
the decision to remove the abutment. At the time of removal,
the inflammation was moderate (classified as a Holgers grade 2
reaction) for which she was being treated with a topical oint-
ment (Nasumel®, Bfactory Health Products B.V. Rhenen, The
Netherlands). At that point in time, the soft tissue thickness was
approximately 4mm. The abutment was removed under local
anesthesia by unscrewing its internal screw that mounts it to the
osseointegrated implant fixture. The abutment was not attached
to the surrounding soft tissue. A thin layer of surrounding tissue
was excised using a scalpel.
Patient 2 (Table 1) was a 68-year-old male with no relevant
history of disease who had been implanted with an HA-coated
abutment using a linear incision without soft tissue thinning
(32) one year prior to removal. The patient developed minor
to moderate peri-abutment dermatitis several times during the
first few months post-operatively, which were successfully treated
with systemic and topical antibiotics. The patient was found eli-
gible for a cochlear implant (CI) on the side of the abutment
that indicated surgical removal. Upon removal, the patient had
a minor redness (classified as a Holgers grade 1) around the
abutment with a caudal pocket, which resulted from a prior
episode of peri-abutment dermatitis. The soft tissue thickness was
approximately 4mm. The abutment was removed under general
anesthesia by unscrewing its internal screw that mounts it to
the osseointegrated implant fixture. A thin layer of surrounding
tissue was excised using a scalpel after removal of the abutment.
The surgical procedure was combined with the implantation
of the CI.
Scanning Electron Microscopy
The Titanium Abutment
The bare BA300 titanium abutment surface was mostly covered
by a thin, unstructured amorphous material thought to be com-
posed of proteins, lipids, sebum, keratin, compacted cornified
keratinocytes, leukocytes, and components of biofilm such as
extracellular polymeric substance (EPS) (Figure 2). Planktonic
bacteria were also seen (Figure 2E).
The HA-Coated Abutment
The HA-coated abutment (Figure 2B) appeared to be completely
covered by biological material, solely on the parts of the surface
that were coated with HA. The titanium part of the HA-coated
abutment was free of attached tissues. The HA coating was cov-
ered by organized, viable layers of keratinocytes and a layer of
collagen fibers (Cl) (Figure 2D). Only a small amount of epithelial
cells, at the upper regions of the HA coating, showed signs of
cornification and detachment from their surroundings. There
was no presence of accumulation of non-viable corneocytes or
cellular debris. Planktonic bacteria undergoing phagocytosis were
seen, which is evidence of an active immune response (Figure 3).
There were no signs of generalized biofilm formation. There
also seemed to be a protein matrix attached directly to the HA
or to a layer of cells in intimate contact with the HA surface
(Figure 2F).
Histology
The Titanium Abutment
The section of the skin around the titanium abutment shows epi-
dermal stratification (Figure 4A). The stratum corneum, stratum
lucidum, stratum granulosum, stratum spinosum, and stratum
basale with the subsequent transition to the dermis can be seen.
Keratinization increases after the stratum granulosum. The stra-
tum corneum, which is the outer abutment-facing layer, has a
strong presence of cornification and squamation. The total thick-
ness of all the epidermal layers was approximately 300μm. There
were no signs of extensive granulation. Dermal papilla or hair
follicles were absent.
The HA-Coated Abutment
The abutment-facing epidermal layers were stratified and non-
keratinized (Figure 4B). The epidermis, facing the abutment
lacked rete pegs, had a viable flattened outer layer containing
nuclei and there were no signs of cornification or squamation.
The stratum spinosum and stratum basale could be identified.
The total thickness of all the epidermal layers was approximately
120μm. Dermal papilla and hair follicles were absent.
Discussion
Comparison of Results
In summary, the results for these two patients are distinct. The
scanning electronmicroscopy (SEM) analysis showed viable tissue
in intimate contact with the HA coating, indicating effective skin
integration and including signs of an effective immune system.
Such findings were lacking on the titanium abutment or on the
top titanium portion of the HA-coated abutment. The histological
analysis showed that the abutment-facing cell layers only had
nuclei in the case of the HA-coated abutment. There was no
cornification or keratinization present. This can be considered a
prerequisite for the establishment of a viable direct soft tissue-to-
abutment contact.
Skin Integration, Microbiota, and the Immune
Response
A long-term percutaneous implant, starting from its surgical
placement, endures continuous colonization attempts bymicroor-
ganisms. The resulting bacterial selection pressure probably leads
to a distinct, highly specialized, multi-species microbiota possibly
in the form of a biofilm on (26) and around the abutment. This
could provide a partial explanation for the recurrent or persistent
inflammations often encountered in clinical practice. Therefore,
substantial effort is spent on designing implant materials that
resist bacterial colonization, either by bacterial resistant coatings
(14) or by ensuring that there is a skin seal (15). Holgers et al.
(6) previously showed that seven out of nine titanium abutments
had no macroscopically visible materials and no cells attaching to
the abutment surface. Some titanium abutments showed evidence
of amorphous materials, bacteria and fungi, leukocytes and shed
keratinized cells, similar to the results presented here. They con-
cluded that there was no viable attachment in any of the titanium
abutments studied. Mlynski et al. (33) also concluded that soft
tissue does not attach tightly to the titanium bone conduction
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FIGURE 2 | Scanning electron micrographs of the titanium and HA-coated abutment. (A) Titanium abutment. (B) HA-coated abutment. (C) Structured soft
tissue is not present on the titanium abutment (view from the top of the abutment). (D) The sharply delineated area of HA is covered by multiple layers of soft tissues
containing collagen fibers (Cl), Erythrocytes (Er), and connected epithelium (Ec) as opposed to its titanium surface (Ti). (E) The amorphous layer (Am) that is present
on the titanium surface shows a group of planktonic coccoid bacteria (Bac) in presence of a leukocyte (L). (F) This image is a higher magnification of the area with
disrupted epithelial coverage in (B) (F*) and shows a layer containing a matrix of proteins.
hearing implant abutment. Their histological results showed no
signs of skin integration. The skin surrounding the titanium
abutments showed normal keratinization or even hyperkeratosis,
similar to our results. Although the function of the skin’s stratum
corneum is to expel bacteria (34), the presence of a percutaneous
abutment could inhibit the clearance of shed corneocytes into
the peri-abutment pocket that results from the non-adherence of
the tissue to the abutment. This would allow for accumulation of
non-viable materials in which bacteria seem to prosper and could
explain the observation of amorphous structures on top of the
titanium abutment surface in the present investigation. Similar
observations have previously been made around abutments for
bone conduction hearing implants and are described as biofilm
by Monksfield et al. (26).
The role of the immune system in skin integration has received
less attention. The immune response should not be suppressed, as
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FIGURE 3 | Host defense in response to bacteria in the skin–implant interface of the HA-coated abutment. This scanning electron micrograph shows an
overview of the different connected, non-shedding epithelial cells (Ec) on the outer surface of the HA coating [(A) lateral view)]. Immune cells and bacteria are seen.
A close-up view [(B) scale bar= 5μm] shows ongoing phagocytosis in the neighborhood of planktonic rod-shaped bacteria (Bac).
FIGURE 4 | Histologic comparison of skin specimens around the titanium and HA-coated abutment. The skin directly surrounding the titanium abutment
[(A) oblique orientation, abutment-facing surface to the left (Ab)] shows extensive stratified keratinization (K) and cornification (C). The skin directly surrounding the
HA-coated abutment [(B) longitudinal orientation, abutment-facing surface to the right, (Ab)] shows viable stratified layers of epithelial cells (Ec); no keratinization or
shedding is present.
this reduces its capacity to combat infections (13, 14). Tomaintain
a healthy implant site, the current consensus is that vascularized
soft tissue integration not only provides a physical barrier to bac-
teria (28) but also enables the host’s immune defense or systemic
antibiotics to reach areas sensitive to bacterial invasion. It has been
shown in vivo that smooth surfaces have a higher risk of infection
than rough, porous surfaces that display soft tissue ingrowth (27).
At the same time, it is known that bacteria prefer a rough surface
(35). The discrepancy between these two observations could pos-
sibly be explained by the role of the host’s immune system. When
the host’s immune system is not inhibited or compromised by the
avascular physical barrier of strong cornification that can form
around titanium abutments, it could possibly be more capable of
preventing and healing infections by means of enhanced access.
Moreover, a barrier without cornification would mimic the
physiological junctional epithelium around teeth or the one that
develops around dental implants (6, 36, 37). Junctional epithelium
is a highly specialized cell layer whose function is to bridge the
soft tissues to teeth while acting as a barrier which is permeable
for an immune response to prevent bacteria in dental plaques
from invading the host further (36). Several features of junctional
epithelium correspond to observations made when analyzing the
soft tissues around the HA-coated abutment in this investigation.
Examples include the prominent immune recruitment in response
to bacteria and viable peri-abutment epithelia without keratiniza-
tion and cornification. In this context, it is interesting to note
that junctional epithelium can form de novo from gingival oral
keratinocytes by phenotypic change (38). Phenotypic change may
be hypothesized to also play a role in the skin integration seenwith
HA-coated abutments.
Shear Stresses and Physical Locking
The tolerance of the integrated skin–implant interface to push
and pull forces could be important in the advent of inflammation
(39). Holt et al. (39) suggested that three different regions develop
around the implant to cope with these forces. The interface region
serves as a first attachment. The transition region bridges the inter-
face region and the stress-absorbance region. The latter functions
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as a buffer for “push and pull” forces between the rigid fixated
implant and the surrounding tissues. These regions could also be
partially identified here in the tissue surrounding and covering the
HA-coated abutment. The interface region could be present in the
form of a basal lamina attached to the HA of which the observed
protein matrix would be a part. An alternative explanation would
be that fibroblasts created an extracellular matrix for epidermal
cells to connect to (11). The ability of epithelial cells to attach to
titanium implants using hemidesmosomes or a basal lamina has
been shown before (40–42). The attachment is expected to have
a strong relationship to wound healing as discussed in the next
paragraph. The transition region and stress-absorbance region are
less distinctly characterized in the results presented here. Collagen
fibers can have stress-absorbent properties andwere also observed
in the layer of tissue on top of the HA-coated abutment. But
their function and orientation is not yet clear around implants
(43, 44).
Both abutments easily detached from the surrounding tissue
during the removal procedure. In line with the other results,
this was to be expected for the titanium abutment. Clinicians
have been manually replacing titanium abutments for decades.
By contrast, a layer of tissue still remained directly attached to
the HA-coated part of the HA-coated abutment. This suggests
that the linkage between the HA-coated abutment and the directly
attaching tissues is stronger than the connection between the latter
and the surrounding skin.
Wound Healing and Skin Integration
The stage is set for skin integrationwhen awound is surgically cre-
ated. The host’s healing response quickly commences with blood
clotting on the abutment surface. Over time, granulation tissue is
formed around the abutment and keratinocytes can be expected
to migrate for re-epithelialization. Upon reaching the abutment,
components from both the epidermis and dermis can be respon-
sible for the actual attachment as previously discussed. Residing
in the granulation tissue, fibroblasts can attach to the abutment
surface and create an extracellular matrix (42). From the epider-
mis, migrating keratinocytes could possibly use hemidesmosome
complexes to attach to the abutment directly or by connecting
to an extracellular matrix surrounding the abutment that has
been previously created. The attached tissues on the HA-coated
abutment here could support either theory. On the host side
of the interface, keratinocytes can connect to each other using
desmosomes to close the breach of skin integrity that was the
end-goal of wound healing and skin integration.
Future Studies
The present proof-of-principle study allows for assessing the ultra-
structural composition and degree of attachment. It does not allow
for a conclusive identification of the different cells and layers
and how these are interconnected. Moreover, it is not unlikely
that the attachment differs within and between patients in rela-
tion to (traumatic) skin shear stresses, time, complications, and
patient characteristics. Future studies are needed to investigate
if the observations and hypotheses presented in this paper can
be further corroborated by immunological, microbiological (45),
and molecular cell biology research. This could result in a clearer
definition of what skin integration is or should be.
Whether the observed skin integration of the HA-coated abut-
ment also results in an enhanced clinical outcome in terms of
a reduction in inflammatory reactions has not been investigated
here. This is currently being investigated in a randomized con-
trolled trial that compares the clinical outcomes in patients with
an HA-coated abutment placed using tissue preservation surgery
and patients with a titanium abutment placed using traditional
soft tissue reduction techniques (30).
Limitations
The aim of the study was not to confirm that current titanium
abutments are unable to achieve soft tissue integration since this
has been shown before (6, 7). Indeed, this investigation solely
focused on providing a proof-of-principle that the HA-coated
abutment can achieve soft tissue integration in humans. The
patients described here have possible confounding factors, such
as their history, age, the different surgical procedure, and clinical
course. Therefore, ideally, the results should be confirmed in a sta-
tistically powered sample size where the two different abutments
are placed in two randomly selected groups using an equal surgical
procedure; however, conducting such research is difficult due to
practical and ethical limitations.
Conclusion
Evidence that the percutaneous HA-coated abutment for bone
conduction hearing implants can achieve integration with the
surrounding skin in human subjects was presented for the first
time. An ongoing prospective comparative clinical trial should
establish if it also leads to a reduced incidence or severity of
inflammatory skin reactions. These “proof-of-principle” results
may also be of interest to other long-term percutaneous implants
in medicine as well.
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